<DOC>
	<DOCNO>NCT00836940</DOCNO>
	<brief_summary>The study aim evaluate efficacy safety GRC 8200 type 2 diabetes mellitus patient . The study involve six week wash period two week run period patient currently mono-therapy two week run period drug naïve patient . This placebo control study . One five treatment arm placebo . The duration treatment 12 week .</brief_summary>
	<brief_title>A Clinical Study GRC 8200 Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female patient ≥30 year age At screening , females nonchildbearing potential female childbearing potential adequate contraception Has establish clinical diagnosis type 2 diabetes mellitus least 3 month prior screen period Is treat diabetes either diet exercise alone , monotherapy antidiabetic drug Has HbA1c value screen 6.5 % 10 % Has type 1 diabetes Is female lactate pregnant Has history acute metabolic diabetic complication Has clinically significant disease type 2 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>GRC 8200</keyword>
</DOC>